comparemela.com

Page 2 - Swoop Portable News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hyperfine (HYPR) to Release Quarterly Earnings on Monday

Hyperfine (NASDAQ:HYPR – Get Free Report) is scheduled to be announcing its earnings results after the market closes on Monday, May 13th. Analysts expect the company to announce earnings of ($0.14) per share for the quarter. Hyperfine has set its Q1 2024 guidance at EPS and its FY 2024 guidance at EPS.Parties that wish to […]

Hyperfine, Inc - Leading Institutions Enroll First Alzheimer s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study

GUILFORD - Hyperfine, Inc. , the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance brain imaging system-the Swoop.

Contrasting Heart Tronics (OTCMKTS:HRTT) & Hyperfine (NASDAQ:HYPR)

Heart Tronics (OTCMKTS:HRTT – Get Free Report) and Hyperfine (NASDAQ:HYPR – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability. Insider & Institutional Ownership 15.0% of Hyperfine shares are […]

Hyperfine, Inc Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional Athletes

Hyperfine, Inc Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional Athletes
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Financial Survey: Fc Global Realty (OTCMKTS:FCRE) and Hyperfine (NASDAQ:HYPR)

Fc Global Realty (OTCMKTS:FCRE – Get Free Report) and Hyperfine (NASDAQ:HYPR – Get Free Report) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends and analyst recommendations. Analyst Ratings This is a […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.